GlassScriptPhysician profile
Patricia Tung
NPI 1104978857
$98,082.91
in general payments reported to CMS, 2019-2025
11 companies · $50K in 2025
The $50K reported for 2025 was more than what 95% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,747 · 2020: $2,500 · 2021: $8,225 · 2022: $12K · 2023: $18K · 2024: $1,228 · 2025: $50K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Travel and Lodging: $8,381 · Food and Beverage: $4,839 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,318.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,850.00 |
| Travel and Lodging | $8,380.54 |
| Food and Beverage | $4,838.71 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,025.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $26,548.70 | 2024-2025 | Farapulse, Versacross Large Access Solution, Versacross Rf Wire |
| Abbott Laboratories | $20,805.95 | 2022-2025 | Gallant, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Biosense Webster, INC. | $16,390.36 | 2023-2025 | Carto 3, Qdot Micro, Nuvision Ice Catheter |
| Medtronic, INC. | $15,229.22 | 2021-2025 | Micra, Affera Mapping System |
| Medical Device Business Services, INC. | $6,880.09 | 2022-2024 | Carto 3 |
| Medtronic Vascular, INC. | $5,409.91 | 2019 | |
| Zoll Respicardia, INC. | $2,837.34 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $2,088.00 | 2021 | |
| Biotronik INC. | $1,732.41 | 2022-2023 | |
| Elutia, INC. | $137.10 | 2021 | |
| Cordis US Corp. | $23.83 | 2024 | Mynx Venous Vcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Tung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.